The market hasn't valued BlueScope at its true value for over a decade.
This is a pretty resilient performance for bottom of the cycle conditions. EBIT at around $700 million )forecast for the year) isn't a bad effort considering the OLD BlueScope that nearly went bankrupt would have run at losses.
US Steel spreads have slowly increased from their lows which is promising.
- Forums
- ASX - By Stock
- BSL
- Ann: 1H FY2025 Results ASX Release
BSL
bluescope steel limited
Add to My Watchlist
0.60%
!
$22.58

Ann: 1H FY2025 Results ASX Release, page-3
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$22.58 |
Change
0.135(0.60%) |
Mkt cap ! $9.923B |
Open | High | Low | Value | Volume |
$22.32 | $22.63 | $22.20 | $5.996M | 266.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
10 | 660 | $22.57 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$22.58 | 649 | 17 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
13 | 543 | 22.600 |
15 | 1292 | 22.590 |
17 | 1446 | 22.580 |
9 | 1043 | 22.570 |
10 | 930 | 22.560 |
Price($) | Vol. | No. |
---|---|---|
22.610 | 67 | 2 |
22.620 | 606 | 9 |
22.630 | 849 | 15 |
22.640 | 778 | 10 |
22.650 | 2016 | 13 |
Last trade - 14.00pm 26/06/2025 (20 minute delay) ? |
Featured News
BSL (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online